Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Dennis

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2011
Transferrin antibodies into the brainMark S Dennis, Ryan J Watts
Current Opinion in Chemical Biology|April 11, 2013
Bispecific antibodies for delivery into the brainRyan J Watts, Mark S Dennis
The Biochemical Journal|April 5, 2002
Fusion of two distinct peptide exosite inhibitors of Factor VIIaMartin Roberge, Mark Peek, Daniel Kirchhofer, et al.
Journal of Molecular Biology|July 9, 2004
High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffoldChingwei V Lee, Wei-Ching Liang, Mark S Dennis, et al.
The Journal of Biological Chemistry|July 18, 2002
Albumin binding as a general strategy for improving the pharmacokinetics of proteinsMark S Dennis, Min Zhang, Y Gloria Meng, et al.
Protein Engineering, Design & Selection : PEDS|April 20, 2006
The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albuminAllen Nguyen, Arthur E Reyes, Min Zhang, et al.
Cancer Research|January 11, 2007
Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agentMark S Dennis, Hongkui Jin, Debra Dugger, et al.
Mabs|May 5, 2011
Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4Daniela Bumbaca, Anne Wong, Elizabeth Drake, et al.
Science Translational Medicine|May 27, 2011
Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis targetY Joy Yu, Yin Zhang, Margaret Kenrick, et al.
Cancer Research|May 19, 2007
Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor modelsYoujun Chen, Suzanna Clark, Terence Wong, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2011
Transferrin antibodies into the brainMark S Dennis, Ryan J Watts
Current Opinion in Chemical Biology|April 11, 2013
Bispecific antibodies for delivery into the brainRyan J Watts, Mark S Dennis
The Biochemical Journal|April 5, 2002
Fusion of two distinct peptide exosite inhibitors of Factor VIIaMartin Roberge, Mark Peek, Daniel Kirchhofer, et al.
Journal of Molecular Biology|July 9, 2004
High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffoldChingwei V Lee, Wei-Ching Liang, Mark S Dennis, et al.
The Journal of Biological Chemistry|July 18, 2002
Albumin binding as a general strategy for improving the pharmacokinetics of proteinsMark S Dennis, Min Zhang, Y Gloria Meng, et al.
Protein Engineering, Design & Selection : PEDS|April 20, 2006
The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albuminAllen Nguyen, Arthur E Reyes, Min Zhang, et al.
Cancer Research|January 11, 2007
Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agentMark S Dennis, Hongkui Jin, Debra Dugger, et al.
Mabs|May 5, 2011
Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4Daniela Bumbaca, Anne Wong, Elizabeth Drake, et al.
Science Translational Medicine|May 27, 2011
Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis targetY Joy Yu, Yin Zhang, Margaret Kenrick, et al.
Cancer Research|May 19, 2007
Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor modelsYoujun Chen, Suzanna Clark, Terence Wong, et al.
Pageof 5